Literature DB >> 6486193

Confirmation of the preoperative diagnoses for hysterectomy.

N C Lee, R C Dicker, G L Rubin, H W Ory.   

Abstract

Few previous studies have examined the relationship between the preoperative and pathologic diagnoses for hysterectomy. To determine the percentage of preoperative diagnoses that were confirmed by pathologic examination, we analyzed data from the Collaborative Review of Sterilization, a multicenter study of hysterectomies and tubal sterilizations in women aged 15 to 44 years. Data were collected from patient interviews and chart reviews. Of the 1851 women included in this study, 1283 (69%) had abdominal hysterectomies and 568 (31%) had vaginal hysterectomies. Overall, 52% of the hysterectomies were performed for a preoperative diagnosis that could potentially be confirmed by pathologic examination. Pathologic examination actually confirmed the preoperative diagnosis of endometrial hyperplasia in 95% of the cases, cervical intraepithelial neoplasia in 89%, leiomyomas in 84%, pelvic inflammatory disease in 75%, adenomyosis in 48%, and endometriosis in 47%. Among all of the potentially confirmable diagnoses, 80% were confirmed. The remaining 48% of the women who had hysterectomies had preoperative diagnoses that were not amenable to confirmation by pathology. Most of these were for one of three diagnoses: menstrual bleeding disorders, pelvic pain, or pelvic relaxation. In 47% of these cases, pathologic examination showed leiomyoma or adenomyosis; no abnormalities were found in 38% of these cases.

Entities:  

Mesh:

Year:  1984        PMID: 6486193     DOI: 10.1016/s0002-9378(84)90366-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  An unexpected diagnosis of adenomyosis in the subfertile woman.

Authors:  Tia Hunjan; Andrew Davidson
Journal:  BMJ Case Rep       Date:  2015-02-27

2.  Adenomyosis in Pakistani women: four year experience at the Aga Khan University Medical Centre, Karachi.

Authors:  H Shaikh; K S Khan
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

Review 3.  Surgical interventions for the management of chronic pelvic pain in women.

Authors:  Mathew Leonardi; Mike Armour; Tatjana Gibbons; Adele Cave; Sawsan As-Sanie; George Condous; Ying C Cheong
Journal:  Cochrane Database Syst Rev       Date:  2021-12-20

4.  Accumulation of nerve growth factor and its receptors in the uterus and dorsal root ganglia in a mouse model of adenomyosis.

Authors:  Yan Li; Shao-fen Zhang; Shi-en Zou; Xian Xia; Lei Bao
Journal:  Reprod Biol Endocrinol       Date:  2011-03-08       Impact factor: 5.211

5.  Infertility and adenomyosis.

Authors:  Sebastiano Campo; Vincenzo Campo; Giuseppe Benagiano
Journal:  Obstet Gynecol Int       Date:  2011-12-26

6.  Concentration of non-steroidal anti-inflammatory drugs in the pelvic floor muscles: an experimental comparative rat model.

Authors:  Hung-Yen Chin; Eileen Changchien; Mei-Fung Lin; Chi-Hsin Chiang; Chin-Jung Wang
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

Review 7.  Adenomyosis and its impact on women fertility.

Authors:  Elisabetta Garavaglia; Serafini Audrey; Inversetti Annalisa; Ferrari Stefano; Tandoi Iacopo; Corti Laura; Candiani Massimo
Journal:  Iran J Reprod Med       Date:  2015-06

8.  Converting potential abdominal hysterectomy to vaginal one: laparoscopic assisted vaginal hysterectomy.

Authors:  Jyothi Shetty; Asha Shanbhag; Deeksha Pandey
Journal:  Minim Invasive Surg       Date:  2014-03-05

9.  An audit of indications, complications, and justification of hysterectomies at a teaching hospital in India.

Authors:  Deeksha Pandey; Kriti Sehgal; Aashish Saxena; Shripad Hebbar; Jayaram Nambiar; Rajeshwari G Bhat
Journal:  Int J Reprod Med       Date:  2014-01-02

Review 10.  Unveiling the Pathogenesis of Adenomyosis through Animal Models.

Authors:  Xi Wang; Giuseppe Benagiano; Xishi Liu; Sun-Wei Guo
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.